News and events
Press releases
Nicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China
Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023
Shareholders Letter – April 2023
Nicox: 2023 Ordinary Shareholder Meeting to be held on June 1, 2023
Events and conferences
Glaucoma 360
February 2-4, 2023
|
San Francisco, U.S.
https://glaucoma360.org/
https://glaucoma360.org/
MidCap Event
February 9, 2023
|
Frankfurt, Germany
http://frankfurt2023.midcapevents.com/
http://frankfurt2023.midcapevents.com/
American Glaucoma Society (AGS) 2022 Annual Meeting
March 2-5, 2023
|
Austin, U.S.
https://www.americanglaucomasociety.net/ags-events/annual-meeting
https://www.americanglaucomasociety.net/ags-events/annual-meeting
Investor Access Event
April 4-5, 2023
|
Paris, France
Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual meeting
April 23-27, 2023
|
New Orleans, U.S.
https://www.arvo.org/annual-meeting/
https://www.arvo.org/annual-meeting/
BioEquity Europe 2023
May 14-16, 2023
|
Dublin, Irland
https://informaconnect.com/bioequity-europe-2023/
https://informaconnect.com/bioequity-europe-2023/
BIO International Convention
June 5-8, 2023
|
Boston, U.S.
https://www.bio.org/events/bio-international-convention
https://www.bio.org/events/bio-international-convention
Spring Midcap Event
June 22, 2023
|
Paris, France
10th World Glaucoma Congress (WGC) –
June 28, 2023 – July 1, 2023
|
Rome, Italy
https://worldglaucomacongress.org/
https://worldglaucomacongress.org/